DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 215 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,385 | +14.3% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $6,460 | +31.7% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $4,905 | -7.8% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $5,320 | +6.4% | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -16.7% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | +20.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -28.6% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -63.2% | 500 | -50.0% | 0.00% | – |
| Q3 2021 | $19,000 | +90.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | -99.9% | 1,000 | -50.0% | 0.00% | – |
| Q1 2021 | $19,660,000 | +491400.0% | 2,000 | +100.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -55.6% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |